NCT06077851

Continuous Monitoring of Vital Signs at Home (WARD HOME II)

Continuous Monitoring With Real-time Transmission of Vital Signs to Healthcare Professionals From Patients at Home

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 83 (actual)
• Sponsor: Bispebjerg Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study aims to investigate the use of wireless, continuous monitoring in patients at home including the frequency of alarms triggered by abnormal vital parameters and their significance for (re)hospitalisation/Serious Adverse Events(SAE) and/or death within 30 days.

Detailed description

Acute hospital admissions challenge the capacity of the healthcare system. Readmission is common among patients with chronic medical diseases, and many patients admitted for acute conditions are often subsequently observed at the hospital for hours and often with one overnight stay for observation purposes alone. Recent medico technical research has allowed continuous and wireless monitoring of patients' vital signs in-hospital, but the practice at home remains uninvestigated. However, the technology has the potential to relieve hospital overcrowding by offering continuous and real time analytics of vital signs in high-risk patients at home.

Conditions

• Vital Sign Monitoring
• Clinical Deterioration
• Hospital At Home

Interventions

Type	Name	Description
DEVICE	Continuously monitoring	Included patients are monitored with WARD equipment the first days after discharge. Monitoring will last for a maximum of three days.

Timeline

• Start date: 2023-10-03
• Primary completion: 2025-10-30
• Completion: 2025-11-30
• First posted: 2023-10-11
• Last updated: 2026-03-13

Locations

1 site across 1 country: Denmark